Le Lézard
Classified in: Health, Science and technology
Subject: CFG

Government of Canada invests $6 million to drive growth in B.C.'s life sciences sector


Funding will help adMare BioInnovations create a 30,000 square foot innovation centre in Vancouver to propel local biotech research and development

VANCOUVER, BC, Feb. 7, 2025 /CNW/ - British Columbia is home to a thriving life sciences sector, with over 2,000 companies employing more than 20,000 people across the province. However, the lack of specialized research facilities in B.C.'s Lower Mainland means that early-stage life sciences companies do not have the necessary resources to expand and advance their innovations.

Today, the Honourable Harjit S. Sajjan, Minister of Emergency Preparedness and Minister responsible for the Pacific Economic Development Agency of Canada (PacifiCan), announced $6 million in PacifiCan funding for adMare BioInnovations to support the establishment of a new life sciences innovation centre in Vancouver. This investment will contribute to the construction of the 30,000 square foot facility, including installation of plumbing and electrical systems, HVAC upgrades and the purchase of laboratory equipment.

The centre, expected to open in 2026, will help meet the critical demand for wet lab space in Vancouver. A wet lab is a highly regulated research space where life sciences companies conduct hands-on experiments and develop innovative drug therapies. Many life sciences companies get their start at research centres and universities where they have access to a wet lab. However, they eventually need access to their own labs to scale up.

Once complete, the new centre will provide access to turnkey wet lab and office space for up to 10 life sciences companies at a time, allowing them to grow and develop life-saving therapies. These companies will also benefit from adMare's talent development programs which fosters innovation and growth in B.C.'s life sciences ecosystem.

Today's investment, through PacifiCan's Regional Innovation Ecosystems program, is expected to maintain and create over 100 quality jobs in British Columbia. The new centre will also help create solutions to global health challenges and strengthen B.C.'s leadership position in life sciences innovation.

Quotes

"In British Columbia's thriving life sciences sector, local innovators are creating health solutions needed around the world. By partnering with organizations like adMare BioInnovations and investing in critical lab infrastructure in Vancouver, PacifiCan is creating the right conditions for industry growth. The PacifiCan funding announced today will provide companies with the resources they need to succeed here at home and reinforces B.C.'s reputation as a hub for science and innovation."

-The Honourable Harjit S. Sajjan, Minister of Emergency Preparedness and Minister responsible for the Pacific Economic Development Agency of Canada

"PacifiCan's investment in the adMare Innovation Centre will expand our capacity to support emerging life sciences companies, helping them scale, attract external investment, and create high-quality jobs in Canada. As companies grow and move on to their own facilities, they make space for the next generation of startups - fuelling a continuous cycle of innovation that strengthens the industry, drives economic growth, and delivers meaningful advancements for patients."

-Gordon McCauley, President and CEO, adMare BioInnovations

Quick Facts

Associated Links

Stay connected
Follow PacifiCan on X and LinkedIn 
Toll-Free Number: 1-888-338-9378
TTY (telecommunications device for the hearing impaired): 
1-877-303-3388

SOURCE Pacific Economic Development Canada


These press releases may also interest you

at 17:46
The objective was to assess dissolvable microneedle technology and identify top licensing partner companies with the right technological competencies, clinical capabilities, and commercial readiness using secondary and primary intelligence. The...

at 17:31
DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a BCMA-directed, genetically modified autologous T-cell immunotherapy, which involves reprogramming a patient's T cells with a...

at 17:10
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to market, has been recognized as the Best Contract...

at 16:41
For the second consecutive year, East Bay Surgery Center and Middlesex Endoscopy Center have been recognized by U.S. News & World Report as among the 2025 Best Ambulatory Surgery Centers in the United States. Both East Bay and Middlesex are operated...

at 16:30
Researchers with Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative diseases, have announced the...

at 16:15
Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced fourth quarter and full year 2024 financial results and highlighted recent...



News published on and distributed by: